The stock of Alere Inc (NYSE:ALR) is a huge mover today! About 927,460 shares traded hands or 30.86% up from the average. Alere Inc (NYSE:ALR) has declined 27.87% since April 14, 2016 and is downtrending. It has underperformed by 32.55% the S&P500.
The move comes after 5 months positive chart setup for the $3.38B company. It was reported on Nov, 16 by Barchart.com. We have $64.00 PT which if reached, will make NYSE:ALR worth $2.33B more.
Alere Inc (NYSE:ALR) Ratings Coverage
Out of 7 analysts covering Alere (NYSE:ALR), 4 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 57% are positive. Alere has been the topic of 14 analyst reports since August 4, 2015 according to StockzIntelligence Inc. Wedbush maintained the shares of ALR in a report on Thursday, November 5 with “Neutral” rating. The rating was downgraded by Jefferies to “Hold” on Tuesday, February 2. The company was downgraded on Tuesday, February 2 by Craig Hallum. On Tuesday, August 4 the stock rating was maintained by BTIG Research with “Buy”. As per Tuesday, March 15, the company rating was downgraded by BTIG Research. As per Thursday, September 29, the company rating was maintained by Canaccord Genuity. TheStreet upgraded the shares of ALR in a report on Friday, August 14 to “Hold” rating. The stock has “Buy” rating given by Craig Hallum on Friday, April 29. Leerink Swann upgraded Alere Inc (NYSE:ALR) on Thursday, April 28 to “Outperform” rating. As per Tuesday, February 2, the company rating was downgraded by Canaccord Genuity.
According to Zacks Investment Research, “Alere Inc., formerly known as Inverness Medical Innovations, Inc., provides products and services, which focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Alere is headquartered in Waltham, Massachusetts.”
Insitutional Activity: The institutional sentiment decreased to 0.89 in 2016 Q2. Its down 0.01, from 0.9 in 2016Q1. The ratio fall, as 28 funds sold all Alere Inc shares owned while 79 reduced positions. 24 funds bought stakes while 71 increased positions. They now own 73.65 million shares or 1.98% less from 75.14 million shares in 2016Q1.
Keeley Asset holds 0.9% or 520,100 shares in its portfolio. Invesco accumulated 1.98 million shares or 0.03% of the stock. Sphinx Trading Limited Partnership holds 0.4% of its portfolio in Alere Inc (NYSE:ALR) for 4,800 shares. Gamco Investors Et Al holds 0.15% of its portfolio in Alere Inc (NYSE:ALR) for 528,225 shares. Blackrock Advsr accumulated 48,162 shares or 0% of the stock. Allianz Asset Mgmt Ag last reported 486,026 shares in the company. Gardner Lewis Asset L P owns 250,454 shares or 1.1% of their US portfolio. First Tru Advsr L P has 0.05% invested in the company for 382,859 shares. The California-based Cap Rech Glob Investors has invested 0% in Alere Inc (NYSE:ALR). Farallon Mgmt Lc accumulated 480,000 shares or 0.28% of the stock. Mcclain Value Mgmt Limited Co has 2.96% invested in the company for 83,522 shares. Lombard Odier Asset (Usa) last reported 0.03% of its portfolio in the stock. Endurance Wealth Mngmt has invested 0% of its portfolio in Alere Inc (NYSE:ALR). Vertex One Asset Inc accumulated 0.27% or 40,100 shares. Edgepoint Investment has 3.12M shares for 2.27% of their US portfolio.
More notable recent Alere Inc (NYSE:ALR) news were published by: Prnewswire.com which released: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” on November 07, 2016, also Fool.com with their article: “Alere Inc. Has Been Left for Dead, With Its Shares Down 13%” published on November 04, 2016, Businesswire.com published: “IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alere …” on November 07, 2016. More interesting news about Alere Inc (NYSE:ALR) were released by: Prnewswire.com and their article: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of …” published on November 16, 2016 as well as Medgadget.com‘s news article titled: “Research Focused On the Alere Inc. (ALR) – Product Pipeline Analysis, 2016” with publication date: November 15, 2016.
ALR Company Profile
Alere Inc., incorporated on May 11, 2001, is a well-known provider of health information through diagnostic tests. The Company’s divisions include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing activities related to its role as the exclusive maker of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.